Tirzepatide 10 mg
A dual GIP and GLP-1 receptor co-agonist research peptide.
What is Tirzepatide?
Tirzepatide is a synthetic peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.
How Tirzepatide is studied
Tirzepatide is studied in metabolic-signalling research for its combined activity at two incretin receptors, and is frequently compared with single-agonist peptides and with the triple agonist Retatrutide.
Specifications
Handling & reconstitution
Tirzepatide is supplied as a lyophilised (freeze-dried) powder. For research, reconstitute with bacteriostatic water and store the reconstituted vial refrigerated. Our reconstitution calculator works out units and concentration for any vial size and target. See the guide on reconstituting Tirzepatide for a step-by-step.
Frequently asked questions
What is Tirzepatide supplied as?
Tirzepatide is supplied as a lyophilised powder in a 3 mL vial (10 mg), for laboratory and in-vitro research use only.
How is Tirzepatide stored?
Store sealed vials cold (−20 °C) and protected from light. Once reconstituted for research, keep the vial refrigerated.
How fast is delivery in Australia?
Orders ship by tracked express post, 1–3 business days to most Australian addresses. Orders placed before 3pm AEST on a business day ship the same day.
Is Tirzepatide for human use?
No. Tirzepatide is supplied strictly for laboratory and in-vitro research use and is not for human or veterinary consumption, food, or drug use.